COVID-19 Vaccines — Your Questions Answered

Living with PKD
Back to Search
Recorded April 27, 2021


April 27, 2021
7 p.m. CDT

In this session, we will learn about the FDA approved vaccines currently on the market and answer your questions about these vaccines. We will also take a peek into what we know about life after vaccination for kidney disease patients and transplant recipients.

Learning objectives

  • Summarize general information about COVID-19 vaccine safety and efficacy.
  • Understand how to apply the information learn to specific health needs to develop a vaccine action plan.

Learn more

Want to learn more about COVID-19 and PKD?


Patrick Dean, M.D.

Mayo Clinic

Dr. Patrick Dean is the Surgical Director of the Kidney/Pancreas Transplant Program and a Consultant and Associate Professor of Surgery in the Division of Transplantation Surgery at Mayo Clinic Rochester. He received his undergraduate degree from Princeton University and subsequently graduated from the University of Alabama School of Medicine in Birmingham, AL. He completed his general surgery residency and fellowship in abdominal transplantation surgery at the Mayo Clinic in Rochester, Minnesota. He was appointed to the faculty at Mayo Clinic in 2006. In addition to his clinical duties, Dr. Dean is the program director of the abdominal transplantation surgery fellowship program and Co-chair of the Enterprise Transplant Informatics Workgroup. Dr. Dean’s clinical and research interests include kidney and pancreas transplantation, preemptive kidney transplantation, living donor kidney transplantation, transplantation for polycystic kidney disease and antibody-mediated kidney graft injury. He is a Fellow of the American College of Surgeons, as well as a member of both the American Society of Transplant Surgeons and the American Society of Transplantation. He has been a member of the Membership and Professional Standards Committee of UNOS and the Fellowship Training Committee of the American Society of Transplant Surgeons. Currently he is the Chair of the Program Accreditation Committee of the ASTS Transplant Accreditation & Certification Council. In addition, he serves on the Clinical Policy Board of LifeSource and the Kidney Pancreas Committee of LifeSource.

Naim S. Issa, M.D.

Mayo Clinic

Dr. Naim Issa is currently a transplant nephrologist and consultant at the Mayo Clinic in Rochester, MN. He had his training in internal medicine and nephrology at the Cleveland Clinic in Ohio and his transplant nephrology at the Mayo Clinic, Rochester, Minnesota. His main interests are kidney and pancreas transplantation, living kidney donation, and kidney paired exchange.

Related Resources

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

El propósito de este manual es proporcionar información sobre la enfermedad renal poliquística autosómica dominante (ERPAD). Será un documento útil para aquellas personas que tienen la enfermedad, para las que tienen riesgo de tenerla debido a un progenitor afectado, así como para los familiares y amigos involucrados. No está dirigido a los pacientes con enfermedad renal poliquística autosómica recesiva (ERPAR). Para los pacientes con esta enfermedad, hay un manual disponible en En lo sucesivo, nos referiremos a la ERPAD simplemente como ERP.



Tuesday, December 1, 2021 | 11 a.m. CST

Dr. Roman-Ulrich Müller of University Hospital Cologne gives an update on the KETO-PKD Study (begun Oct. 2020).

Understanding Lab Results

Understanding Lab Results

Tuesday, November 16, 2021 | 7 p.m. CDT

Labs provide you and your doctor with valuable information about your overall health and your kidney function. It is important to understand the labs that your doctor requests, track your results, and know when specific labs are or are not within the normal range.